PEPMAB B V has a total of 11 patent applications. Its first patent ever was published in 2016. It filed its patents most often in United States, Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are ULTRAHUMAN ONE LTD, CMS PEPTIDES PATENT HOLDING CO and CMS PEPTIDES PATENT HOLDING COMPANY LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 2 | |
#2 | Australia | 1 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EAPO (Eurasian Patent Organization) | 1 | |
#6 | EPO (European Patent Office) | 1 | |
#7 | Hungary | 1 | |
#8 | Republic of Korea | 1 | |
#9 | Mexico | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Therapeutic chemical compounds | |
#3 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Back Jaap Willem | 10 |
#2 | Boshuizen Ronald | 10 |
#3 | Turkstra Johan | 10 |
#4 | Puijk Wouter Cornelis | 10 |
#5 | Schwamborn Klaus Heinrich | 5 |
#6 | Timmerman Peter | 2 |
#7 | Jaap Willem Back | 1 |
#8 | Wouter Cornelis Puijk | 1 |
#9 | Johan Turkstra | 1 |
#10 | Ronald Boshuizen | 1 |
Publication | Filing date | Title |
---|---|---|
EP3334457A1 | Humanized anti-ccr7 receptor antibodies |